12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Deals

Galapagos, Ono Pharmaceutical deal

The BioFocus service division of Galapagos will use its SilenceSelect technology to discover validated targets for allergic diseases including atopic dermatitis and...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >